We are performing deep next-generation sequencing on stocks of Hepatitis C virus to identify the mutations that occur in the population and relate these to clinical consequences such as resistance to immunological or other anti-viral treatments.
| Name | Affiliation |
|---|---|
| Patrick Minx | The Genome Institute, Washington University School of Medicine |